These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 17592075)

  • 21. Angioplasty versus bare metal stenting for superficial femoral artery lesions.
    Chowdhury MM; McLain AD; Twine CP
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD006767. PubMed ID: 24959692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pilot trial of cryoplasty or conventional balloon post-dilation of nitinol stents for revascularization of peripheral arterial segments: the COBRA trial.
    Banerjee S; Das TS; Abu-Fadel MS; Dippel EJ; Shammas NW; Tran DL; Zankar A; Varghese C; Kelly KC; Weideman RA; Little BB; Reilly RF; Addo T; Brilakis ES
    J Am Coll Cardiol; 2012 Oct; 60(15):1352-9. PubMed ID: 22981558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One-year outcomes for recanalization of long superficial femoral artery chronic total occlusions with the Viabahn stent graft.
    Farraj N; Srivastava A; Pershad A
    J Invasive Cardiol; 2009 Jun; 21(6):278-81. PubMed ID: 19494404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis.
    Sabeti S; Schillinger M; Amighi J; Sherif C; Mlekusch W; Ahmadi R; Minar E
    Radiology; 2004 Aug; 232(2):516-21. PubMed ID: 15286322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of exercise on frequency of stent fracture in the superficial femoral artery.
    Iida O; Nanto S; Uematsu M; Morozumi T; Kotani J; Awata M; Onishi T; Ito N; Sera F; Minamiguchi H; Akahori H; Nagata S
    Am J Cardiol; 2006 Jul; 98(2):272-4. PubMed ID: 16828607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angioplasty versus stenting for superficial femoral artery lesions.
    Twine CP; Coulston J; Shandall A; McLain AD
    Cochrane Database Syst Rev; 2009 Apr; (2):CD006767. PubMed ID: 19370653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomized study.
    Becquemin JP; Favre JP; Marzelle J; Nemoz C; Corsin C; Leizorovicz A
    J Vasc Surg; 2003 Mar; 37(3):487-94. PubMed ID: 12618680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial.
    Tepe G; Laird J; Schneider P; Brodmann M; Krishnan P; Micari A; Metzger C; Scheinert D; Zeller T; Cohen DJ; Snead DB; Alexander B; Landini M; Jaff MR;
    Circulation; 2015 Feb; 131(5):495-502. PubMed ID: 25472980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of total endoluminal superficial femoral artery bypass.
    Gable D
    J Cardiovasc Surg (Torino); 2011 Oct; 52(5):683-700. PubMed ID: 21799474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [PTA versus Palmaz stent placement in femoropopliteal artery stenoses: results of a multicenter prospective randomized study (REFSA)].
    Grenacher L; Saam T; Geier A; Müller-Hülsbeck S; Cejna M; Kauffmann GW; Richter GM
    Rofo; 2004 Sep; 176(9):1302-10. PubMed ID: 15346266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional and clinical outcomes of nitinol stenting with and without abciximab for complex superficial femoral artery disease: a randomized trial.
    Ansel GM; Silver MJ; Botti CF; Rocha-Singh K; Bates MC; Rosenfield K; Schainfeld RM; Laster SB; Zander C
    Catheter Cardiovasc Interv; 2006 Feb; 67(2):288-97. PubMed ID: 16408299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angioplasty and elective stenting of de novo versus recurrent femoropopliteal lesions: 1-year follow-up.
    Schillinger M; Mlekusch W; Haumer M; Sabeti S; Ahmadi R; Minar E
    J Endovasc Ther; 2003 Apr; 10(2):288-97. PubMed ID: 12877612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia.
    Liistro F; Porto I; Angioli P; Grotti S; Ricci L; Ducci K; Falsini G; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
    Circulation; 2013 Aug; 128(6):615-21. PubMed ID: 23797811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous angioplasty and stenting of the superficial femoral artery.
    Surowiec SM; Davies MG; Eberly SW; Rhodes JM; Illig KA; Shortell CK; Lee DE; Waldman DL; Green RM
    J Vasc Surg; 2005 Feb; 41(2):269-78. PubMed ID: 15768009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutting-balloon angioplasty versus balloon angioplasty as treatment for short atherosclerotic lesions in the superficial femoral artery: randomized controlled trial.
    Poncyljusz W; Falkowski A; Safranow K; Rać M; Zawierucha D
    Cardiovasc Intervent Radiol; 2013 Dec; 36(6):1500-1507. PubMed ID: 23576210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cilostazol reduces angiographic restenosis after endovascular therapy for femoropopliteal lesions in the Sufficient Treatment of Peripheral Intervention by Cilostazol study.
    Iida O; Yokoi H; Soga Y; Inoue N; Suzuki K; Yokoi Y; Kawasaki D; Zen K; Urasawa K; Shintani Y; Miyamoto A; Hirano K; Miyashita Y; Tsuchiya T; Shinozaki N; Nakamura M; Isshiki T; Hamasaki T; Nanto S;
    Circulation; 2013 Jun; 127(23):2307-15. PubMed ID: 23652861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries.
    Sabeti S; Mlekusch W; Amighi J; Minar E; Schillinger M
    J Endovasc Ther; 2005 Feb; 12(1):6-12. PubMed ID: 15683273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease.
    Malas MB; Enwerem N; Qazi U; Brown B; Schneider EB; Reifsnyder T; Freischlag JA; Perler BA
    J Vasc Surg; 2014 Jan; 59(1):129-35. PubMed ID: 23891488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized Comparison of Paclitaxel-Eluting Balloon and Stenting Versus Plain Balloon Plus Stenting Versus Directional Atherectomy for Femoral Artery Disease (ISAR-STATH).
    Ott I; Cassese S; Groha P; Steppich B; Hadamitzky M; Ibrahim T; Kufner S; Dewitz K; Hiendlmayer R; Laugwitz KL; Schunkert H; Kastrati A; Fusaro M
    Circulation; 2017 Jun; 135(23):2218-2226. PubMed ID: 28424222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study.
    Bosiers M; Torsello G; Gissler HM; Ruef J; Müller-Hülsbeck S; Jahnke T; Peeters P; Daenens K; Lammer J; Schroë H; Mathias K; Koppensteiner R; Vermassen F; Scheinert D
    J Endovasc Ther; 2009 Jun; 16(3):261-9. PubMed ID: 19642788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.